A Study of Sabroxy™ (Oroxylum Indicum Extract) for Improving Cognitive Function in Adults With Mild Memory Concerns

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

February 8, 2021

Study Completion Date

February 8, 2021

Conditions
Mild Cognitive Impairment (MCI)Cognitive Dysfunction, Cognitive DisorderMemory Problems
Interventions
DIETARY_SUPPLEMENT

Sabroxy™ (Oroxylum indicum extract)

Sabroxy™ is a standardized extract derived from the bark of Oroxylum indicum. In this study, participants will receive Sabroxy™ in capsule form. Each capsule contains a fixed dose of the extract and will be administered orally at a regimen of one capsule twice daily after meals for 12 weeks. The supplement is provided in visually identical containers to maintain blinding and is compared to a placebo control. The intervention is designed to evaluate potential improvements in cognitive function, including memory, attention, and executive performance, as well as effects on circulating Brain-Derived Neurotrophic Factor (BDNF) levels.

OTHER

Placebo

The placebo is an inert capsule formulated to be visually identical to the Sabroxy™ capsules in size, shape, color, and packaging. It contains inactive ingredients only, with no active botanical extract. The placebo will be administered orally at the same regimen as the active intervention: one capsule taken twice daily after meals for 12 weeks. The use of a placebo ensures blinding of participants and study staff, allowing accurate comparison of cognitive and biomarker outcomes between groups.

Trial Locations (1)

94132

San Francisco Research Institute, San Francisco

All Listed Sponsors
lead

SF Research Institute, Inc.

NETWORK

NCT07189754 - A Study of Sabroxy™ (Oroxylum Indicum Extract) for Improving Cognitive Function in Adults With Mild Memory Concerns | Biotech Hunter | Biotech Hunter